USE OF SULFASALAZINE AS AN INHIBITOR OF THE FORMATION OF ADVANCED GLYCATION END PRODUCTS
The invention relates to the field of healthcare, namely, to the treatment of socially significant diseases, such as complications of diabetes mellitus, atherosclerosis, rheumatoid arthritis, osteoarthritis, neurodegenerative diseases including Alzheimer's and Parkinson's diseases, catarac...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | SPASOV, Aleksandr Alekseevich PETROV, Vladimir Ivanovich BALAKIN, BKonstantin Valerevich SHTYRLIN, Yurij Grigorevich KUZNETSOVA, Valentina Andreevna STRELNIK, Aleksej Dmitrievich |
| description | The invention relates to the field of healthcare, namely, to the treatment of socially significant diseases, such as complications of diabetes mellitus, atherosclerosis, rheumatoid arthritis, osteoarthritis, neurodegenerative diseases including Alzheimer's and Parkinson's diseases, cataract, age-related diseases, etc. The essence of the invention is the use of sulfasalazine (international non-proprietary name; synonyms: Salazosulfapyridine, Azopyrine, Asulfidine, Salazopyridin, Salazopyrin, Salazosulfapyridine, Salicylazosulfapyridin, Salisulf, Sulfasalazyn, Sulphasalazine) of the general formula I as an inhibitor of the formation of advanced glycation end-products: |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2023210871A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2023210871A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2023210871A13</originalsourceid><addsrcrecordid>eNrjZIgIDXZV8HdTCA71cXMMdvRxjPL0c1VwDFZw9FPw9PPwdPIM8Q8CKQjxcFVw8w_ydQzx9PcDCTi6hDn6Obu6KLj7RDpDRF39XBQCgvxdQp1DgnkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXxosJGBkbGRoYGFuaGjoTFxqgCAzDHL</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>USE OF SULFASALAZINE AS AN INHIBITOR OF THE FORMATION OF ADVANCED GLYCATION END PRODUCTS</title><source>esp@cenet</source><creator>SPASOV, Aleksandr Alekseevich ; PETROV, Vladimir Ivanovich ; BALAKIN, BKonstantin Valerevich ; SHTYRLIN, Yurij Grigorevich ; KUZNETSOVA, Valentina Andreevna ; STRELNIK, Aleksej Dmitrievich</creator><creatorcontrib>SPASOV, Aleksandr Alekseevich ; PETROV, Vladimir Ivanovich ; BALAKIN, BKonstantin Valerevich ; SHTYRLIN, Yurij Grigorevich ; KUZNETSOVA, Valentina Andreevna ; STRELNIK, Aleksej Dmitrievich</creatorcontrib><description>The invention relates to the field of healthcare, namely, to the treatment of socially significant diseases, such as complications of diabetes mellitus, atherosclerosis, rheumatoid arthritis, osteoarthritis, neurodegenerative diseases including Alzheimer's and Parkinson's diseases, cataract, age-related diseases, etc. The essence of the invention is the use of sulfasalazine (international non-proprietary name; synonyms: Salazosulfapyridine, Azopyrine, Asulfidine, Salazopyridin, Salazopyrin, Salazosulfapyridine, Salicylazosulfapyridin, Salisulf, Sulfasalazyn, Sulphasalazine) of the general formula I as an inhibitor of the formation of advanced glycation end-products:</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230706&DB=EPODOC&CC=US&NR=2023210871A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230706&DB=EPODOC&CC=US&NR=2023210871A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SPASOV, Aleksandr Alekseevich</creatorcontrib><creatorcontrib>PETROV, Vladimir Ivanovich</creatorcontrib><creatorcontrib>BALAKIN, BKonstantin Valerevich</creatorcontrib><creatorcontrib>SHTYRLIN, Yurij Grigorevich</creatorcontrib><creatorcontrib>KUZNETSOVA, Valentina Andreevna</creatorcontrib><creatorcontrib>STRELNIK, Aleksej Dmitrievich</creatorcontrib><title>USE OF SULFASALAZINE AS AN INHIBITOR OF THE FORMATION OF ADVANCED GLYCATION END PRODUCTS</title><description>The invention relates to the field of healthcare, namely, to the treatment of socially significant diseases, such as complications of diabetes mellitus, atherosclerosis, rheumatoid arthritis, osteoarthritis, neurodegenerative diseases including Alzheimer's and Parkinson's diseases, cataract, age-related diseases, etc. The essence of the invention is the use of sulfasalazine (international non-proprietary name; synonyms: Salazosulfapyridine, Azopyrine, Asulfidine, Salazopyridin, Salazopyrin, Salazosulfapyridine, Salicylazosulfapyridin, Salisulf, Sulfasalazyn, Sulphasalazine) of the general formula I as an inhibitor of the formation of advanced glycation end-products:</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZIgIDXZV8HdTCA71cXMMdvRxjPL0c1VwDFZw9FPw9PPwdPIM8Q8CKQjxcFVw8w_ydQzx9PcDCTi6hDn6Obu6KLj7RDpDRF39XBQCgvxdQp1DgnkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXxosJGBkbGRoYGFuaGjoTFxqgCAzDHL</recordid><startdate>20230706</startdate><enddate>20230706</enddate><creator>SPASOV, Aleksandr Alekseevich</creator><creator>PETROV, Vladimir Ivanovich</creator><creator>BALAKIN, BKonstantin Valerevich</creator><creator>SHTYRLIN, Yurij Grigorevich</creator><creator>KUZNETSOVA, Valentina Andreevna</creator><creator>STRELNIK, Aleksej Dmitrievich</creator><scope>EVB</scope></search><sort><creationdate>20230706</creationdate><title>USE OF SULFASALAZINE AS AN INHIBITOR OF THE FORMATION OF ADVANCED GLYCATION END PRODUCTS</title><author>SPASOV, Aleksandr Alekseevich ; PETROV, Vladimir Ivanovich ; BALAKIN, BKonstantin Valerevich ; SHTYRLIN, Yurij Grigorevich ; KUZNETSOVA, Valentina Andreevna ; STRELNIK, Aleksej Dmitrievich</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2023210871A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>SPASOV, Aleksandr Alekseevich</creatorcontrib><creatorcontrib>PETROV, Vladimir Ivanovich</creatorcontrib><creatorcontrib>BALAKIN, BKonstantin Valerevich</creatorcontrib><creatorcontrib>SHTYRLIN, Yurij Grigorevich</creatorcontrib><creatorcontrib>KUZNETSOVA, Valentina Andreevna</creatorcontrib><creatorcontrib>STRELNIK, Aleksej Dmitrievich</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SPASOV, Aleksandr Alekseevich</au><au>PETROV, Vladimir Ivanovich</au><au>BALAKIN, BKonstantin Valerevich</au><au>SHTYRLIN, Yurij Grigorevich</au><au>KUZNETSOVA, Valentina Andreevna</au><au>STRELNIK, Aleksej Dmitrievich</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>USE OF SULFASALAZINE AS AN INHIBITOR OF THE FORMATION OF ADVANCED GLYCATION END PRODUCTS</title><date>2023-07-06</date><risdate>2023</risdate><abstract>The invention relates to the field of healthcare, namely, to the treatment of socially significant diseases, such as complications of diabetes mellitus, atherosclerosis, rheumatoid arthritis, osteoarthritis, neurodegenerative diseases including Alzheimer's and Parkinson's diseases, cataract, age-related diseases, etc. The essence of the invention is the use of sulfasalazine (international non-proprietary name; synonyms: Salazosulfapyridine, Azopyrine, Asulfidine, Salazopyridin, Salazopyrin, Salazosulfapyridine, Salicylazosulfapyridin, Salisulf, Sulfasalazyn, Sulphasalazine) of the general formula I as an inhibitor of the formation of advanced glycation end-products:</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2023210871A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | USE OF SULFASALAZINE AS AN INHIBITOR OF THE FORMATION OF ADVANCED GLYCATION END PRODUCTS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T14%3A47%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SPASOV,%20Aleksandr%20Alekseevich&rft.date=2023-07-06&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2023210871A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |